Aurisco Pharmaceutical Co.,Ltd. (605116.SS)
CNY 20.8
(-0.48%)
CNY 20.8
(-0.48%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 71.69 Million CNY | 335.6% |
| 2022 | 16.45 Million CNY | 18.34% |
| 2021 | 13.9 Million CNY | 105.51% |
| 2020 | 6.76 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 104.4 Million CNY | 57.91% |
| 2024 Q3 | 817.25 Million CNY | 605.25% |
| 2024 Q2 | 115.88 Million CNY | 21.37% |
| 2023 Q3 | 38.33 Million CNY | 175.01% |
| 2023 FY | 71.69 Million CNY | 335.6% |
| 2023 Q2 | 13.94 Million CNY | -6.23% |
| 2023 Q1 | 14.86 Million CNY | -9.69% |
| 2023 Q4 | 71.69 Million CNY | 87.02% |
| 2022 Q4 | 16.45 Million CNY | -17.23% |
| 2022 Q3 | 19.88 Million CNY | 17.62% |
| 2022 Q2 | 16.9 Million CNY | -2.35% |
| 2022 Q1 | 17.31 Million CNY | 24.48% |
| 2022 FY | 16.45 Million CNY | 18.34% |
| 2021 Q3 | 2.29 Million CNY | 229745900.21% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 Q4 | 13.9 Million CNY | 505.42% |
| 2021 FY | 13.9 Million CNY | 105.51% |
| 2021 Q2 | 1.00 CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 FY | 6.76 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |